Minimally Invasive Surgery in Pediatric Surgical Oncology

Children (Basel). 2018 Nov 26;5(12):158. doi: 10.3390/children5120158.

Abstract

The application of minimally invasive surgery (MIS) to resect pediatric solid tumors offers the potential for reduced postoperative morbidity with smaller wounds, less pain, fewer surgical site infections, decreased blood loss, shorter hospital stays, and less disruption to treatment regimens. However, significant controversy surrounds the question of whether a high-fidelity oncologic resection of childhood cancers can be achieved through MIS. This review outlines the diverse applications of MIS to treat pediatric malignancies, up to and including definitive resection. This work further summarizes the current evidence supporting the efficacy of MIS to accomplish a definitive, oncologic resection as well as appropriate patient selection criteria for the minimally invasive approach.

Keywords: Wilms tumor; minimally invasive surgery; neuroblastoma; pediatric cancer; rhabdomyosarcoma.

Publication types

  • Review